Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET)

Pain. 2002 Oct;99(3):589-598. doi: 10.1016/S0304-3959(02)00266-X.

Abstract

The role of the supraspinal endogenous opioid system in pain processing has been investigated in this study using positron emission tomography imaging of [11C]-carfentanil, a synthetic, highly specific mu opioid receptor (mu-OR) agonist. Eight healthy volunteers were studied during a baseline imaging session and during a session in which subjects experienced pain induced by applying capsaicin topically to the dorsal aspect of the left hand. A pain-related decrease in brain mu-OR binding was observed in the contralateral thalamus consistent with competitive binding between [11C]-carfentanil and acutely released endogenous opioid peptides. This decrease varied directly with ratings of pain intensity. These results suggest that the supraspinal mu-opioid system is activated by acute pain and thus may play a substantial role in pain processing and modulation in pain syndromes.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Area Under Curve
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Capsaicin
  • Carbon Radioisotopes / metabolism
  • Fentanyl / analogs & derivatives*
  • Fentanyl / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Narcotics / metabolism
  • Neural Pathways / diagnostic imaging
  • Neural Pathways / metabolism
  • Pain / chemically induced
  • Pain / diagnostic imaging*
  • Pain / metabolism
  • Pain Measurement / methods*
  • Receptors, Opioid, mu / metabolism*
  • Tomography, Emission-Computed / methods*

Substances

  • Carbon Radioisotopes
  • Narcotics
  • Receptors, Opioid, mu
  • carfentanil
  • Capsaicin
  • Fentanyl